BridgeBio Competitors and Similar CompaniesClear all
BridgeBio's competitors and similar companies include Gubra.
 BridgeBio BridgeBio is a company focused on discovering and developing drugs for patients with grievous genetic diseases. |  Gubra Gubra is a biotech company that provides drug discovery programs and pre-clinical contract research services. | |
Founding Date | Founding Date 2014 | Founding Date 2008 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Palo Alto, US HQ | Locations Hørsholm, DK HQ |
Employees | Employees 24863% increase | Employees 2672% increase |
Financial | ||
Revenue (est.) | Revenue (est.) $502.1m (FY, 2025) | Revenue (est.) kr2.6b (FY, 2025) |
Cost of goods | Cost of goods $21m (FY, 2025) | Cost of goods kr73.6m (FY, 2025) |
Gross profit | Gross profit $481.1m (FY, 2025) | Gross profit kr2.6b (FY, 2025) |
Net income | Net income ($732.9m) (FY, 2025) | Net income kr1.7b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Gubra
HQ
Hørsholm, DK
Employees
267↑ 2% increase
Gubra is a biotech company that provides drug discovery programs and pre-clinical contract research services.
View company